St. John’s wort has been used for centuries in traditional medicine of many cultures, and nowadays it is well-known as a clinically important antidepressant drug. Considering the rising market demand for Hyperici herba, quality control of crude drug is of paramount importance. In this paper we performed HPLC-DAD chemical profiling of St. John’s wort tea samples obtained at local markets, pharmacies and health food stores in the Balkan Peninsula countries, Austria and Turkey. Furthermore, water alcoholic extracts of the collected samples were evaluated in terms of their antioxidant potential, as well as the ability to inhibit biologically important enzymes such as acetylcholinesterase, monoamine oxidases A and B (MAO-A and MAO-B), α-amylase and α-glucosidase. Significant variability within the samples in the quantities of hypericin, hyperforin, rutin, quercetin, gallic, chlorogenic, caffeic and p-hydroxybenzoic acid was noticed. Chemotaxonomic modelling enabled the identification of three clusters of samples based on the quantities of rutin, hypericin and hyperforin. Generally, the extracts exhibited a significant potential to inhibit MAO-A (median IC50 = 10.01 μg/mL) and α-glucosidase (median IC50 = 12.40 μg/mL). The results of antioxidant potential evaluation suggest strong neutralization of hydroxyl and nitroso radicals, but moderate inhibition of lipid peroxidation process. Overall, the conducted study emphasizes the possibility of St. John’s wort teas quality control, taking into account unavoidable variability of chemical profile as well. The stated is of great importance when grinding degree of herbal material excludes taxonomic identification of biological origin as an option within quality control.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Ng QX, Venkatanarayanan N, Ho CY (2017) Clinical use of Hypericum perforatum (St John's wort) in depression: a meta-analysis. J Affect Disord 210:211–221
Smith T, Gillespie M, Eckl V, Knepper J, Reynolds C (2019) Herbal supplement sales in US increase by 9.4% in 2018. HerbalGram 123:62–73
Welz AN, Emberger-Klein A, Menrad K (2019) The importance of herbal medicine use in the German health-care system: prevalence, usage pattern, and influencing factors. BMC Health Serv Res 19:952. https://doi.org/10.1186/s12913-019-4739-0
Biagi M, Pecorari R, Appendino G, Miraldi E, Magnano AR, Governa P, Cettolin G, Giachetti D (2016) Herbal products in Italy: the thin line between phytotherapy, nutrition and parapharmaceuticals; a normative overview of the fastest growing market in Europe. Pharmaceuticals. 9. https://doi.org/10.3390/ph9040065
Božin B, Kladar N, Grujić N, Anačkov G, Samojlik I, Gavarić N, Čonić BS (2013) Impact of origin and biological source on chemical composition, anticholinesterase and antioxidant properties of some St. John’s wort species (Hypericum spp., Hypericaceae) from the Central Balkans. Molecules 18(10):11733–11750
Robson N (2003) The genus Hypericum. In: Ernst E (ed) Hypericum: the genus Hypericum. Taylor & Francis, London, pp 1–22
Booker A, Agapouda A, Frommenwiler DA, Scotti F, Reich E, Heinrich M (2018) St John's wort (Hypericum perforatum) products–an assessment of their authenticity and quality. Phytomedicine 40:158–164
Kladar N, Srđenović B, Grujić N, Bokić B, Rat M, Anačkov G, Božin B (2015) Ecologically and ontogenetically induced variations in phenolic compounds and biological activities of Hypericum maculatum subsp. maculatum, Hypericaceae. Braz J Bot 38(4):703–715
Bruni R, Sacchetti G (2009) Factors affecting polyphenol biosynthesis in wild and field grown St. John’s Wort (Hypericum perforatum L. Hypericaceae/Guttiferae). Molecules 14(2):682–725
McCutcheon A (2017) Adulteration of Hypericum perforatum. Botanical adulterants bulletin
Kladar N, Mrđanović J, Anačkov G, Šolajić S, Gavarić N, Srđenović B, Božin B (2017) Hypericum perforatum: synthesis of active principles during flowering and fruitification - novel aspects of biological potential. Evid Based Complement Alternat Med 2017:1–11. https://doi.org/10.1155/2017/2865610
Sagratini G, Ricciutelli M, Vittori S, Öztürk N, Öztürk Y, Maggi F (2008) Phytochemical and antioxidant analysis of eight Hypericum taxa from Central Italy. Fitoterapia 79(3):210–213
Çirak C, Radušienė J, Karabük BS, Janulis V (2007) Variation of bioactive substances and morphological traits in Hypericum perforatum populations from northern Turkey. Biochem Syst Ecol 35(7):403–409
Maleš Ž, Brantner AH, Sović K, Hazler Pilepić K (2006) Comparative phytochemical and antimicrobial investigations of Hypericum perforatum L. subsp. perforatum and H. perforatum subsp. angustifolium (DC.) Gaudin. Acta Pharma 56:359–367
Martonfi P, Repčák M, Ciccarelli D, Garbari F (2001) Hypericum perforatum L. - chemotype without rutin from Italy. Biochem Syst Ecol 29(6):659–661
Brenn A, Grube M, Jedlitschky G, Fischer A, Strohmeier B, Eiden M, Keller M, Groschup MH, Vogelgesang S (2014) St. John's wort reduces beta-amyloid accumulation in a double transgenic Alzheimer's disease mouse model-role of P-glycoprotein. Brain Pathol 24(1):18–24
Cao Z, Wang F, Xiu C, Zhang J, Li Y (2017) Hypericum perforatum extract attenuates behavioral, biochemical, and neurochemical abnormalities in aluminum chloride-induced Alzheimer's disease rats. Biomed Pharmacother 91:931–937
Hashimoto K (2015) Minocycline and St. John's wort as therapeutic drugs for human tauopathy. Biol Psychiatry 78:e39. https://doi.org/10.1016/j.biopsych.2015.04.025
Baranowska-Wojcik E, Szwajgier D, Winiarska-Mieczan A (2020) Honey as the potential natural source of cholinesterase inhibitors in Alzheimer's disease. Plant Foods Hum Nutr 75(1):30–32
Sacher J, Houle S, Parkes J, Rusjan P, Sagrati S, Wilson AA, Meyer JH (2011) Monoamine oxidase a inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study. J Psychiatry Neurosci 36(6):375–382
Yazdankhah S, Hojjati M, Azizi MH (2019) The antidiabetic potential of black mulberry extract-enriched pasta through inhibition of enzymes and glycemic index. Plant Foods Hum Nutr 74(1):149–155
Nowicka P, Wojdylo A, Laskowski P (2018) Inhibitory potential against digestive enzymes linked to obesity and type 2 diabetes and content of bioactive compounds in 20 cultivars of the peach fruit grown in Poland. Plant Foods Hum Nutr 73(4):314–320
Can OD, Ozturk Y, Ozturk N, Sagratini G, Ricciutelli M, Vittori S, Maggi F (2011) Effects of treatment with St. John's wort on blood glucose levels and pain perceptions of streptozotocin-diabetic rats. Fitoterapia 82(4):576–584
Stage TB, Pedersen RS, Damkier P, Christensen MMH, Feddersen S, Larsen JT, Højlund K, Brøsen K (2015) Intake of St John's wort improves the glucose tolerance in healthy subjects who ingest metformin compared with metformin alone. Br J Clin Pharmacol 79(2):298–306
Oliveira AI, Pinho C, Sarmento B, Dias ACP (2016) Neuroprotective activity of Hypericum perforatum and its major components. Front Plant Sci 7:1004
The Ministry of Science and Technological Development, Republic of Serbia (Grant number OI 172058) supported this research work.
Conflict of Interest
All of the authors declare no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Kladar, N., Anačkov, G., Srđenović, B. et al. St. John’s Wort Herbal Teas – Biological Potential and Chemometric Approach to Quality Control. Plant Foods Hum Nutr 75, 390–395 (2020). https://doi.org/10.1007/s11130-020-00823-1
- Enzyme inhibition
- Herbal teas
- Hypericum perforatum
- Quality control